EUVIMEDEUVIMED entdecken
Crossref

Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease

Hongsheng Yu, Yinan Huang, Mingkai Li, Hao Jiang, Bilan Yang, Xiaoli Xi, Abdukyamu Smayi, Bin Wu iD, Yidong Yang iD

Journal of Gastroenterology and Hepatology · 2024

DOI: 10.1111/jgh.16673 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Hongsheng Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University, No. 600 Tianhe Road, Guangzhou, 510630, China. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Liver, Disease Progression. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province for Distinguished Young Scholar, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Liver stiffness measurements (LSMs) are promising for monitoring disease progression or regression. We assessed the prognostic significance of dynamic changes in LSM over time on liver‐related events (LREs) and death in patients with chronic hepatitis B (CHB) and compensated advanced chronic liver disease (cACLD).

Methods

This retrospective study included 1272 patients with CHB and cACLD who underwent at least two measurements, including LSM and fibrosis score based on four factors (FIB‐4). ΔLSM was defined as [(follow‐up LSM − baseline LSM)/baseline LSM × 100]. We recorded LREs and all‐cause mortality during a median follow‐up time of 46 months. Hazard ratios (HRs) and confidence intervals (CIs) for outcomes were calculated using Cox regression.

Results

Baseline FIB‐4, baseline LSM, ΔFIB‐4, ΔLSM, and ΔLSM/year were independently and simultaneously associated with LREs (adjusted HR, 1.04, 95% CI, 1.00–1.07; 1.02, 95% CI, 1.01–1.03; 1.06, 95% CI, 1.03–1.09; 1.96, 95% CI, 1.63–2.35, 1.02, 95% CI, 1.01–1.04, respectively). The baseline LSM combined with the ΔLSM achieved the highest Harrell's C (0.751), integrated AUC (0.776), and time‐dependent AUC (0.737) for LREs. Using baseline LSM and ΔLSM, we proposed a risk stratification method to improve clinical applications. The risk proposed stratification based on LSM performed well in terms of prognosis: low risk ( n = 390; reference), intermediate risk ( n = 446; HR = 3.38), high risk ( n = 272; HR = 5.64), and extremely high risk ( n = 164; HR = 11.11).

Conclusions

Baseline and repeated noninvasive tests measurement allow risk stratification of patients with CHB and cACLD. Combining baseline and dynamic changes in the LSM improves prognostic prediction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicLiverDisease ProgressionHumansMaleFemalePrognosisMiddle AgedRetrospective StudiesAdultElasticity Imaging TechniquesLiver Cirrhosis

Stichwörter der Autor:innen

FibroScanchronic hepatitis Bcompensated advanced chronic liver diseaseliver‐related eventsprognosis

Autor:innen und Institutionen

  • Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University, No. 600 Tianhe Road, Guangzhou, 510630, China.
  • Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China.
  • Department of Gastrointestinal Endoscopy Center, The Eighth Affiliated Hospital, Sun Yat-sen University, 518033, Shenzhen, China.

ORCID-Profile: Bin Wu, Yidong Yang

Förderung

  • Natural Science Foundation of Guangdong Province for Distinguished Young Scholar
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • National Key Research and Development Program of China
  • Science Fund for Distinguished Young Scholars of Guangdong Province

Zitieren

APA

Yu, H., Huang, Y., Li, M., Jiang, H., Yang, B., Xi, X., Smayi, A., Wu, B., & Yang, Y. (2024). Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16673

Vancouver

Yu H, Huang Y, Li M, Jiang H, Yang B, Xi X, et al. Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16673

BibTeX
@article{Yu2024,
  author = {Yu, Hongsheng and Huang, Yinan and Li, Mingkai and Jiang, Hao and Yang, Bilan and Xi, Xiaoli and Smayi, Abdukyamu and Wu, Bin and Yang, Yidong},
  title = {Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1111/jgh.16673}
}
Kostenlos starten →